No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache

No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache

Abstract Recent studies have indicated that long-term neurological sequelae after COVID-19 are not accompanied by an increase of canonical biomarkers of central nervous system injury in blood, but subgroup stratifications are lacking. This is a particular concern in chronic headache, which can be a...

Full description

Bibliographic Details
Main Authors: Laura de Boni, Alexandru Odainic, Natalie Gancarczyk, Luisa Kaluza, Christian P. Strassburg, Xenia A. K. Kersting, Joseph M. Johnson, Ullrich Wüllner, Susanne V. Schmidt, Jacob Nattermann, Gabor C. Petzold
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Neurological Research and Practice
Subjects:
Post-acute sequelae of SARS-CoV-2 infection
Post-COVID-19
Headache
NfL
GFAP
Biomarkers
Online Access:https://doi.org/10.1186/s42466-022-00217-5

Internet

https://doi.org/10.1186/s42466-022-00217-5

Similar Items